Transforming Growth Factor-β Concerning Malarial Infection and Severity: A Systematic Review and Meta-Analysis
Issued Date
2022-10-01
Resource Type
eISSN
24146366
Scopus ID
2-s2.0-85140580239
Journal Title
Tropical Medicine and Infectious Disease
Volume
7
Issue
10
Rights Holder(s)
SCOPUS
Bibliographic Citation
Tropical Medicine and Infectious Disease Vol.7 No.10 (2022)
Suggested Citation
Kotepui K.U., Kwankaew P., Masangkay F.R., Mahittikorn A., Kotepui M. Transforming Growth Factor-β Concerning Malarial Infection and Severity: A Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease Vol.7 No.10 (2022). doi:10.3390/tropicalmed7100299 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/84893
Title
Transforming Growth Factor-β Concerning Malarial Infection and Severity: A Systematic Review and Meta-Analysis
Other Contributor(s)
Abstract
Transforming growth factor-β (TGF-β) is important in the pathophysiology of malaria, but its role in acute and severe malaria is largely unknown. As a result, this study used a meta-analysis approach to investigate the difference in TGF-β levels between several groups of malaria patients and healthy controls. The systematic review protocol was registered at PROSPERO (ID: CRD42022318864). From inception to 7 March 2022, studies that reported TGF-β levels in patients with uncomplicated and healthy controls and patients with severe and uncomplicated malaria were searched in PubMed, Scopus and Embase. The assessment of the quality of the included studies was conducted according to the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. Qualitative and quantitative syntheses were performed to narratively describe and quantitatively pool the mean difference (MD) in TGF-β levels between uncomplicated malaria and healthy controls, and between severe and uncomplicated malaria, using a random-effects model. A total of 1027 relevant articles were identified, and 13 studies were included for syntheses. The meta-analysis results show 233 patients with uncomplicated malaria and 239 healthy controls. Patients with uncomplicated malaria (233 cases) had lower mean TGF-β levels than healthy controls (239 cases; p < 0.01, pooled MD = −14.72 pg/mL, 95% confidence interval (95% CI) = −20.46 to 8.99 pg/mL, I2 = 98.82%, seven studies). The meta-analysis found no difference in mean TGF-β levels between patients with severe malaria (367 cases) and patients with uncomplicated malaria (180 cases; p = 0.11, pooled MD = −6.07 pg/mL, 95% CI = −13.48 to 1.35 pg/mL, I2 = 97.73%, six studies). The meta-analysis demonstrated decreased TGF-β levels in patients with uncomplicated malaria compared to healthy controls. In addition, no difference in TGF-β levels was found between patients with severe and uncomplicated malaria. More research is needed to determine whether TGF-β levels could be a candidate marker for malarial infection or disease severity.